Roquette Frères SA

Roquette is a global leader in plant-based pharmaceutical excipients and specialty carbohydrates, headquartered in Lestrem, France. Founded in 1933, the company generates annual revenue of €4.9 billion and operates 40+ manufacturing sites across the globe, employing 11,000+ people. Roquette's 2025 acquisition of IFF Pharma Solutions transformed it into the world's largest player in oral solid dosage form excipients.

Strengths: Unmatched scale in polyols and starch-derived excipients following the IFF Pharma Solutions acquisition; vertically integrated supply chain from agricultural raw materials to finished pharma-grade excipients; 20+ global R&D centers driving continuous innovation in co-processed excipients and plant-based alternatives; dominant market share in mannitol, sorbitol, and microcrystalline cellulose for pharmaceutical applications; private family ownership enables decade-scale strategic investments without quarterly earnings pressure.
Weaknesses: €87M integration costs from the IFF acquisition contributed to a €265M net loss in 2025; European-centric manufacturing creates exposure to regional energy price volatility and logistics disruptions; limited presence in high-growth lipid nanoparticle and biologics excipient segments compared to Evonik and Croda.